Alpha Cognition Inc is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases, such as Alzheimer’s disease and cognitive impairment with mild traumatic brain injury. The company commercializes ZUNVEYL, an FDA-approved acetylcholinesterase inhibitor for the treatment of mild to moderate Alzheimer’s dementia.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.